JP2016106117A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016106117A5 JP2016106117A5 JP2016032672A JP2016032672A JP2016106117A5 JP 2016106117 A5 JP2016106117 A5 JP 2016106117A5 JP 2016032672 A JP2016032672 A JP 2016032672A JP 2016032672 A JP2016032672 A JP 2016032672A JP 2016106117 A5 JP2016106117 A5 JP 2016106117A5
- Authority
- JP
- Japan
- Prior art keywords
- immunogenic composition
- chlamydia
- antigen
- subject
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 26
- 230000002163 immunogen Effects 0.000 claims 22
- 241000606161 Chlamydia Species 0.000 claims 18
- 239000000427 antigen Substances 0.000 claims 18
- 102000036639 antigens Human genes 0.000 claims 18
- 108091007433 antigens Proteins 0.000 claims 18
- 239000002671 adjuvant Substances 0.000 claims 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 210000000056 organ Anatomy 0.000 claims 4
- 241000606153 Chlamydia trachomatis Species 0.000 claims 3
- 230000005867 T cell response Effects 0.000 claims 3
- 229940038705 chlamydia trachomatis Drugs 0.000 claims 3
- 206010061041 Chlamydial infection Diseases 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 230000003308 immunostimulating effect Effects 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 2
- 239000011707 mineral Substances 0.000 claims 2
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims 1
- 201000000902 chlamydia Diseases 0.000 claims 1
- 208000012538 chlamydia trachomatis infectious disease Diseases 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 230000002519 immonomodulatory effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims 1
- 229930182490 saponin Natural products 0.000 claims 1
- 150000007949 saponins Chemical class 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40516210P | 2010-10-20 | 2010-10-20 | |
| US61/405,162 | 2010-10-20 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013535100A Division JP2013545448A (ja) | 2010-10-20 | 2011-10-20 | クラミジア抗原及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016106117A JP2016106117A (ja) | 2016-06-16 |
| JP2016106117A5 true JP2016106117A5 (enExample) | 2017-01-05 |
Family
ID=45975625
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013535100A Pending JP2013545448A (ja) | 2010-10-20 | 2011-10-20 | クラミジア抗原及びその使用 |
| JP2016032672A Pending JP2016106117A (ja) | 2010-10-20 | 2016-02-24 | クラミジア抗原及びその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013535100A Pending JP2013545448A (ja) | 2010-10-20 | 2011-10-20 | クラミジア抗原及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20120135025A1 (enExample) |
| EP (1) | EP2629793A4 (enExample) |
| JP (2) | JP2013545448A (enExample) |
| AU (2) | AU2011316924A1 (enExample) |
| CA (1) | CA2849391A1 (enExample) |
| WO (1) | WO2012054755A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102458463B (zh) | 2009-05-22 | 2017-01-18 | 健诺西生物科学公司 | 针对ⅱ型单纯疱疹病毒的疫苗：诱发免疫应答的组合物和方法 |
| EP3165531B1 (en) | 2010-03-12 | 2020-11-25 | Children's Medical Center Corporation | Immunogenic composition, vaccine, and uses thereof |
| CA2856697A1 (en) | 2010-11-24 | 2012-06-07 | Genocea Biosciences, Inc. | Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
| JP6199878B2 (ja) * | 2011-11-23 | 2017-09-20 | ジェノセア バイオサイエンシーズ， インコーポレイテッド | 単純ヘルペスウイルス２型に対する核酸ワクチン：免疫応答を誘発する組成物及び方法 |
| CA2900008C (en) | 2013-02-07 | 2025-10-07 | Children's Medical Center Corporation | PROTEIN ANTIGENS THAT CONFER PROTECTION AGAINST COLONIZATION AND/OR PNEUMOCOCCAL DISEASE |
| US10350288B2 (en) | 2016-09-28 | 2019-07-16 | Genocea Biosciences, Inc. | Methods and compositions for treating herpes |
| EP3506625B1 (en) | 2016-10-14 | 2021-06-09 | Panasonic Intellectual Property Management Co., Ltd. | Projection system, projection method, flying object system, and flying object |
| IL281204B2 (en) | 2018-09-12 | 2025-07-01 | Affinivax Inc | Multivalent pneumococcal vaccines |
| EP4284832A1 (en) * | 2021-01-29 | 2023-12-06 | (INSERM) Institut National de la Santé et de la Recherche Médicale | Chlamydia trachomatis antigenic polypeptides and uses thereof for vaccine purposes |
| AU2022342080A1 (en) | 2021-09-09 | 2024-03-28 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7041490B1 (en) * | 1997-11-28 | 2006-05-09 | Serono Genetics Institute, S.A. | Chlamydia trachomatis polynucleotides and vectors, recombinant host cells, DNA chips or kits containing the same |
| AU1722300A (en) * | 1998-11-12 | 2000-05-29 | Regents Of The University Of California, The | Chlamydia pneumoniae genome sequence |
| US20020061848A1 (en) * | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
| EP2168596B1 (en) * | 2001-12-12 | 2012-05-23 | Novartis Vaccines and Diagnostics S.r.l. | Immunisation against chlamydia trachomatis |
| CA2516971A1 (en) * | 2003-02-24 | 2004-09-02 | Institut Pasteur | Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
| CA2526106A1 (en) * | 2003-06-26 | 2005-01-13 | Chiron Corporation | Immunogenic compositions for chlamydia trachomatis |
| ES2389562T3 (es) * | 2004-10-25 | 2012-10-29 | Statens Seruminstitut | Antígenos de Chlamydia trachomatis para uso en vacuna y diagnóstico |
| GB0428394D0 (en) * | 2004-12-24 | 2005-02-02 | Chiron Srl | Saccharide conjugate vaccines |
| US8481057B2 (en) * | 2005-12-22 | 2013-07-09 | Novartis Vaccines & Diagnostics Srl | Chlamydial antigens |
| JP2012505212A (ja) * | 2008-10-09 | 2012-03-01 | ボード・オヴ・リージェンツ，ユニヴァーシティ・オヴ・テキサス・システム | クラミジア感染および疾患の診断および治療のためのクラミジア抗原に関する方法および組成物 |
| EP2379106A4 (en) * | 2008-12-17 | 2012-06-13 | Genocea Biosciences Inc | ANTIGENS OF CHLAMYDIAS AND USES THEREOF |
| CN102438650A (zh) * | 2009-03-06 | 2012-05-02 | 诺华有限公司 | 衣原体抗原 |
-
2011
- 2011-10-20 CA CA2849391A patent/CA2849391A1/en not_active Abandoned
- 2011-10-20 WO PCT/US2011/057143 patent/WO2012054755A1/en not_active Ceased
- 2011-10-20 JP JP2013535100A patent/JP2013545448A/ja active Pending
- 2011-10-20 US US13/277,996 patent/US20120135025A1/en not_active Abandoned
- 2011-10-20 EP EP11835162.6A patent/EP2629793A4/en not_active Withdrawn
- 2011-10-20 AU AU2011316924A patent/AU2011316924A1/en not_active Abandoned
-
2016
- 2016-02-24 JP JP2016032672A patent/JP2016106117A/ja active Pending
- 2016-03-24 US US15/080,324 patent/US20170043005A1/en not_active Abandoned
- 2016-04-21 AU AU2016202528A patent/AU2016202528A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016040284A5 (enExample) | ||
| JP2013545448A5 (enExample) | ||
| JP2011250797A5 (enExample) | ||
| JP2015214545A5 (enExample) | ||
| JP2013507907A5 (enExample) | ||
| HRP20220924T1 (hr) | Imunoterapija zasnovana na pd-l1 | |
| JP2014534202A5 (enExample) | ||
| PH12021553146A1 (en) | Fusion proteins for tuberculosis vaccines | |
| JP2014240404A5 (enExample) | ||
| TW200722101A (en) | Novel composition | |
| CN106659777A8 (zh) | 免疫原性组合产品 | |
| NZ759686A (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | |
| JP2016539946A5 (enExample) | ||
| RU2017104529A (ru) | Композиции neisseria meningitidis и способы их применения | |
| JP2012512257A5 (enExample) | ||
| JP2007538044A5 (enExample) | ||
| WO2015095249A8 (en) | Single chain il-12 nucleic acids, polypeptids, and uses thereof | |
| JP2013518052A5 (enExample) | ||
| WO2013082535A3 (en) | Controlled-release peptide compositions and uses thereof | |
| RU2014127714A (ru) | ВАКЦИНА НА ОСНОВЕ ТОКСИНОВ Clostridium difficile | |
| BRPI1007721B1 (pt) | composição de vacina para uso na indução de uma resposta imunológica contra um rotavírus em um indivíduo, cepa de rotavírus isolado de cdc-9 e cepa de rotavírus isolado de cdc-66 | |
| JP2016514713A5 (enExample) | ||
| JP2015529677A5 (enExample) | ||
| WO2017214596A8 (en) | Compositions and methods for preventing and treating zika virus infection | |
| WO2019072871A3 (en) | Microbiota sequence variants of tumor-related antigenic epitopes |